Anzeige
Mehr »
Login
Freitag, 10.07.2020 Börsentäglich über 12.000 News von 632 internationalen Medien
Neue Silber/Kupfer-Funde mit hohen Graden sorgen für Kurs-Phantasie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JWL4 ISIN: NO0010598683 Ticker-Symbol: HBQ 
Stuttgart
09.07.20
16:25 Uhr
0,816 Euro
-0,008
-0,97 %
1-Jahres-Chart
HOFSETH BIOCARE ASA Chart 1 Jahr
5-Tage-Chart
HOFSETH BIOCARE ASA 5-Tage-Chart
RealtimeGeldBriefZeit
0,8020,85209.07.

Aktuelle News zur HOFSETH BIOCARE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.06.Hofseth Biocare ASA: HBC starts its accelerated COVID-19 Phase 2 clinical trial of OmeGo salmon oil to decrease Acute Respiratory Distress Syndrome and ...3
26.05.BRIEF-Hofseth Biocare ASA: HBC Has Begun Protocol Development For Its Accelerated Phase 2 Clinical Trial8
26.05.Hofseth Biocare ASA: HBC has begun protocol development for its accelerated Phase 2 clinical trial with OmeGo to decrease Acute Respiratory Distress Syndrome ...2
HOFSETH BIOCARE Aktie jetzt für 0€ handeln
25.05.Hofseth Biocare ASA: Completed Annual General Meeting-
22.05.Hofseth Biocare ASA: Proxy Rights at Annual General Meeting-
15.05.BRIEF-Hofseth Biocare: Preclinical Research With OmeGo Demonstrates Potential To Treat Eosinophilic Asthma2
15.05.Hofseth Biocare ASA: Preclinical research with OmeGo demonstrates potential to treat eosinophilic asthma-
15.05.Hofseth Biocare ASA: First Quarter 2020 Financial Report2
11.05.Hofseth Biocare ASA: Two-year research collaboration contract signed with Stanford on the use of Salmon Protein Hydrolysate peptides for the treatment ...1
04.05.Hofseth Biocare ASA: Notice of Annual General Meeting 20203
06.04.Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED1
23.03.Hofseth Biocare ASA: PRIVATE PLACEMENT TOWARDS BOMI FRAMROZE - PRIMARY INSIDER DISCLOSURE2
20.03.Hofseth Biocare ASA: HBC Annual Report and ESG Report 2019-
17.03.Hofseth Biocare ASA: EU DISTRIBUTION AGREEMENT SIGNED WITH PRINOVA EUROPE FOR MARINE BRANDED PRODUCTS RANGE2
26.02.Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER IN HOFSETH BIOCARE ASA1
07.02.Hofseth Biocare ASA: Fourth Quarter 2019 Financial Report5
04.02.Hofseth Biocare ASA: Signs new working capital credit line of NOK 37m-
01.11.19Hofseth Biocare ASA: Third Quarter 2019 Financial Report310Hofseth BioCare had operating revenues of NOK 29.2m (16.9m) in the third quarter of 2019. Cost of Goods Sold (CoGS) amounted to NOK 25.3m (14.3m) in the period. Operational profit (EBITDA) for the...
► Artikel lesen
18.10.19Hofseth Biocare ASA: ENTERS INTO A CONSULTANCY AGREEMENT WITH JAMES BERGER - CONTEMPLATED US LISTING243Hofseth BioCare ASA ("HBC") has today entered into a consultancy agreement with James Berger (through his company Nevera AG). Mr. Berger is a dual British and Italian citizen currently residing in Switzerland...
► Artikel lesen
29.07.19Hofseth Biocare ASA: OVERSUBSCRIBED PRIVATE PLACEMENT SUCCESSFULLY COMPLETED95NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE...
► Artikel lesen
Seite:  Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1